Skip to content

AH Pharma

Active Private limited companyfounded 2025active for 1 yearRue du Village 351, 4000 LiègeKBO/BCE: BE 1029.418.339

Lifetime

1 annual account with figures
peak of €8,265 in 2025
€8,265 
peak of €5,915 in 2025
€5,915 
peak of €5,582 in 2025
€5,582 
€15,747 
Board1 name since 2025
1 director
Documentsfilings and deeds
29-06-202632 days before the deadline
2025micro format
Incorporation 23-10Dividend €8331 establishment registeredFirst year with figures

Key points

from the 2025 annual accounts

Turnover

≈ €45,000 estimated

The micro format states no turnover.

Debts

€15,747 74% of the balance sheet
Suppliers 0%Taxes and wages 27%Other 73%

Position in the sector

€5,582

Less equity than 81% of companies in office administrative support. The sector median is €55,008, over 10,296 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,389 companies had the same profile as AH Pharma has now. Each dot stands for 6 companies, two years later.

96.6%
were still trading
2.1%
stopped another way
1.2%
went bankrupt
  • Micro
  • under 2 years old
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more

Another 0.2% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,389 companies, not a prediction for AH Pharma. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 21-10-2025
  • founderdeed of 23-10-2025
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:1029418339
First establishment Rue du Village 351, Liège
Incorporation Founding capital of €500, 100 shares · Founded by · appointed as director · published on 23-10-2025 · Gazette deed
All 4 events

Comparable companies

same main activity, similar in size and age
Company
AH Pharma Liège €21,329 €8,265 26.2% -
Campana Viri Geel €20,998 €9,567 56.0% -
CAPRIQUARIAN Lebbeke €21,612 €9,378 38.0% -
DYMA Projects Scherpenheuvel-Zichem €17,669 €8,238 50.0% -
Paulivé Damme €20,730 €6,296 40.2% -
FEW Evergem €20,225 €11,334 37.4% -
BERT VAN DYCKE Jabbeke €19,089 €6,923 12.7% -

These companies have the same main activity as AH Pharma: other business support services (NACE 82990). They are comparable in size and age: total assets between €17,700 and €21,600, founded in 2025.

Official details

Source: KBO
Status
Active since 21-10-2025Normal situation
Activity
Other business support servicesNACE 82990and 2 others
Establishment unit
2.380.080.2884000 Liège, since 23-10-2025
Financial year end
31 December
Peppol
Reachable since 06-11-2025
Company details

Annual accounts 2025

€21,329
Filing
Filed on 29-06-2026, 32 days before the end of the filing period
Financials

Insights on AH Pharma

AH Pharma has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €5,582 and a net result of €5,915.

Its solvency ranks better than 32% of 10,284 sector peers (NACE 82) in financial year 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about AH Pharma

What is the company number of AH Pharma?
The company number of AH Pharma is 1029.418.339. The VAT number is the same number with BE in front: BE 1029.418.339.
Where is AH Pharma based?
The registered office is at Rue du Village 351, 4000 Liège.Company details
What does AH Pharma do?
According to the KBO register, the main activity is other business support services (NACE 82990).
What is the legal form of AH Pharma?
AH Pharma is a private limited company (BV).
When was AH Pharma founded?
AH Pharma was founded on 21-10-2025.
Is AH Pharma still active?
Yes, AH Pharma is an active enterprise in the KBO register.
What is the turnover of AH Pharma?
The turnover in financial year 2025 is about €45,000. This figure is estimated from the gross margin of €8,265 and 50 comparable companies (NACE 82990). It probably lies between €17,000 and €96,000. It is a rough estimate.Financials
Is AH Pharma profitable?
In financial year 2025, AH Pharma made a profit of €5,915.
Where can I find the annual accounts of AH Pharma?
AH Pharma filed 1 annual account with the National Bank of Belgium, for financial year 2025.
When are the next annual accounts of AH Pharma due?
AH Pharma must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.